We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.08B
AUM Growth
+$312M
(+4.6%)
Cap. Flow
+$423M
Cap. Flow
% of AUM
5.97%
Top 10 Holdings %
Top 10 Hldgs %
31.95%
Holding
1,367
New
348
Increased
332
Reduced
294
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$188M |
| 2 |
Labcorp
LH
|
+$183M |
| 3 |
AGN
Allergan Inc
AGN
|
+$144M |
| 4 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$93.8M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$82.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brookdale Senior Living
BKD
|
+$104M |
| 2 |
Cardinal Health
CAH
|
+$104M |
| 3 |
AGN
Allergan plc
AGN
|
+$80.7M |
| 4 |
AMAG
AMAG Pharmaceuticals
AMAG
|
+$60.3M |
| 5 |
Elevance Health
ELV
|
+$55.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 47.3% |
| 2 | Consumer Discretionary | 5.38% |
| 3 | Financials | 4.49% |
| 4 | Industrials | 3.37% |
| 5 | Technology | 2.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BNFT
351
DELISTED
Benefitfocus, Inc.
BNFT
| $2.68M | 0.04% |
81,565
+2,103
| +3% | +$55.4K |
|
|
HOUS
352
DELISTED
Anywhere Real Estate
HOUS
| $2.67M | 0.04% |
+60,000
| New | +$2.49M |
|
353
Oracle
ORCL
$367B
| $2.67M | 0.04% |
59,301
+6,353
| +12% | +$259K |
|
354
Teleflex
TFX
$5.86B
| $2.65M | 0.04% |
23,113
-44,720
| -66% | -$5.06M |
|
|
CMLS
355
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $2.64M | 0.04% |
78,048
+21,798
| +39% | +$649K |
|
356
Signet Jewelers
SIG
$3.72B
| $2.63M | 0.04% |
+20,000
| New | +$2.42M |
|
357
Neurogene
NGNE
$670M
| $2.62M | 0.04% |
17,465
+2,525
| +17% | +$360K |
|
358
Nike
NKE
$62.7B
| $2.59M | 0.04% |
53,836
+7,436
| +16% | +$349K |
|
359
Capital One
COF
$129B
| $2.56M | 0.04% |
30,956
-27,092
| -47% | -$2.2M |
|
360
Worthington Enterprises
WOR
$2.74B
| $2.54M | 0.04% |
+137,142
| New | +$3.04M |
|
|
SNDK
361
DELISTED
SANDISK CORP
SNDK
| $2.54M | 0.04% |
25,922
+17,694
| +215% | +$1.69M |
|
362
Louisiana-Pacific
LPX
$5.02B
| $2.53M | 0.04% |
152,733
+48,342
| +46% | +$723K |
|
|
DRC
363
DELISTED
DRESSER-RAND GROUP INC
DRC
| $2.51M | 0.04% |
30,693
-64,133
| -68% | -$5.22M |
|
364
Lam Research
LRCX
$372B
| $2.5M | 0.04% |
315,030
-260,310
| -45% | -$2.02M |
|
365
General Dynamics
GD
$103B
| $2.5M | 0.04% |
18,151
-2,062
| -10% | -$281K |
|
|
OSG
366
Octave Specialty Group
OSG
$250M
| $2.48M | 0.04% |
101,252
-2,404
| -2% | -$56K |
|
367
PUT
Delta Air Lines
DAL
$58.3B
| $2.46M | 0.03% |
50,000
+49,000
| +4,900% | +$2.06M |
|
368
SiriusPoint
SPNT
$2.78B
| $2.45M | 0.03% |
169,216
+4,525
| +3% | +$66.2K |
|
369
Bank of America
BAC
$433B
| $2.45M | 0.03% |
136,769
+13,205
| +11% | +$226K |
|
|
TRQ
370
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $2.44M | 0.03% |
78,664
-90,842
| -54% | -$2.97M |
|
371
DTE Energy
DTE
$29.5B
| $2.42M | 0.03% |
32,912
-87,269
| -73% | -$6.06M |
|
372
Patterson-UTI
PTEN
$3.74B
| $2.38M | 0.03% |
143,379
-2,324,988
| -94% | -$49.1M |
|
373
MetLife
MET
$62.5B
| $2.37M | 0.03% |
49,202
+30,139
| +158% | +$1.43M |
|
|
TC
374
DELISTED
Thompson Creek Metals Company Inc. Ordinary Shares (Canada)
TC
| $2.36M | 0.03% |
1,350,000
| – | – |
|
375
Verizon
VZ
$193B
| $2.34M | 0.03% |
49,953
+19,153
| +62% | +$937K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q4 2014 Portfolio in Review
As of Q4 2014, Visium Asset Management held 1,367 positions worth $7.08B, up 4.6% from $6.77B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $423M of net new capital in Q4 2014, opening 348 new positions and adding to 332 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Brookdale Senior Living, an estimated $104M trimmed.
- Visium Asset Management's largest Q4 2014 buy was BioMarin Pharmaceuticals: 988,391 shares worth $89.4M.
- Visium Asset Management added most to COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, an estimated $188M increase.
- Visium Asset Management's biggest Q4 2014 reduction was Brookdale Senior Living, cutting an estimated $104M.
- Visium Asset Management fully exited AMAG Pharmaceuticals in Q4 2014, selling an estimated $60.3M.
- Visium Asset Management's ten largest holdings make up 32% of its $7.08B portfolio in Q4 2014.
- Visium Asset Management opened 348 new positions and closed 358 in Q4 2014.
- Visium Asset Management's portfolio value rose 4.6% quarter-over-quarter to $7.08B.
Based on Visium Asset Management's 13F filing for Q4 2014, filed 13 Feb 2015.